Page 2 of articles about antimicrobial

Levels of residues from veterinary drugs and other substances found in animals and animal-derived food remain low in the European Union, according to the latest report from EFSA.

Legislation being introduced will make regulations more effective and maintain the UK as an attractive place to market veterinary medicines.

Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to EFSA.

The responsible and prudent use of antimicrobials needs to be improved in all sectors - human, animal, plant/crop, and environment - to preserve their public health benefits.

The project, known as JAMRAI 2, aims at reducing the risk of exposure of citizens to antibiotic-resistant bacteria, and is supported with €50 million under the EU4Health programme, making it the largest EU-funded action on AMR to date.

The U.S. Food and Drug Administration’s Center for Veterinary Medicine published the 2022 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.

European countries have substantially reduced sales of veterinary antibiotics, which translates into a lower risk of bacteria becoming resistant in people and animals.

Italy leads European countries in decreasing the use of antimicrobials.

The "Écoantibio 3" plan (2023-2028) will continue the positive momentum and build on the good results achieved over the last 10 years.

At the European level, Spain is the leading country in reducing the consumption of veterinary antibiotics and the third country in human health.

Sales of antibiotics for use in food-producing animals fell by 9% last year and have reduced by 59% since 2014.

The plan provides stakeholders with a transparent roadmap of the actions that correspond to FDA’s three main veterinary stewardship goals.